Value Bridge — MELROSEWAKEFIELD HEALTHCARE INC
Current $-11M → Target $-6M (+$4.8M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-10.9M
Current EBITDA
$-6.1M
Target EBITDA
+$4.8M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$1.1M
Payer Mix Optimization
$2.6M
Cost to Collect Reduction
$0.9M
Clean Claim Improvement
$0.7M
Volume & Rate Growth
$4.3M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-11M to $-6M. The highest-impact lever is Volume & Rate Growth at $1.7M probability-weighted.
IC talking point: "We see $5M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $53M in equity value creation."